Vir Biotechnology, Inc. (VIR) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-05
(Q2 2026)
— full calendar
Earnings Reports
-
Veir Biotechnology (VIR) Q1 2026: $1.7B Astellas Deal Accelerates Prostate Cancer Pipeline
May 07, 2026
-
Vir Biotechnology (VIR) Q4 2025: $1.7B Astellas Deal Accelerates Dual-Masked T-Cell Engager Platform
February 25, 2026
-
Vir Biotechnology (VIR) Q2 2025: Operating Expenses Down $42M as Pipeline Advances Across Three Registration Trials
August 06, 2025
-
Vir Biotechnology (VIR) Q1 2025: $1B Cash Runway Extends Program Push Through 2027
July 04, 2025